Pinnacle Wealth Planning Services
XENE icon

Pinnacle Wealth Planning Services’s Xenon Pharmaceuticals XENE Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$149 Sell
4
-125
-97% -$7.43K ﹤0.01% 2798
2026
Q2 		$7.79K Buy
129
+125
+3,125% +$6.94K ﹤0.01% 2165
2026
Q1 		$233 Buy
+4
New +$184 ﹤0.01% 2682

Other funds holding XENE

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Elmwood Wealth Management
Elmwood Wealth Management Berkeley, California $416M AUM 11.87% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Pinnacle Wealth Planning Services's XENE Position: Q3 2026 in Review

Pinnacle Wealth Planning Services reduced its Xenon Pharmaceuticals (XENE) stake by 97% in Q3 2026, selling an estimated $7.43K and leaving 4 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

Pinnacle Wealth Planning Services first reported a position in XENE in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.79K in Q2 2026. 32 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Pinnacle Wealth Planning Services held 4 shares of Xenon Pharmaceuticals worth $149 as of Q3 2026.
  • Pinnacle Wealth Planning Services sold 125 Xenon Pharmaceuticals shares in Q3 2026, an estimated $7.43K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2798 holding.
  • Pinnacle Wealth Planning Services first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Xenon Pharmaceuticals position peaked at $7.79K in Q2 2026.
  • 32 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.